Evidence map›Paper›PMID 34423135›Full record

ArticleTrauma surgery & acute care open2021

Damage control laparotomy in trauma: a pilot randomized controlled trial. The DCL trial.

John A Harvin, Sasha D Adams, Shah-Jahan M Dodwad, Kayla D Isbell, Claudia Pedroza, Charles Green, Jon E Tyson, Ethan A Taub, David E Meyer, Laura J Moore and 5 more

Open access · goldAbstract read
In one paragraph

Article in Trauma surgery & acute care open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Primary repair and anastomosis in traumatic bowel injuries: a retrospective cohort study from a European trauma center.European journal of trauma and emergency surgery : official publication of the European Trauma Society · 2026
    Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

John A HarvinDepartment of Surgery, The University of Texas Health Science Center at Houston, Houston, Texas, USA.ORCID 0000-0002-2081-6256
Sasha D AdamsDepartment of Surgery, The University of Texas Health Science Center at Houston, Houston, Texas, USA.
Shah-Jahan M DodwadDepartment of Surgery, The University of Texas Health Science Center at Houston, Houston, Texas, USA.
Kayla D IsbellDepartment of Surgery, The University of Texas Health Science Center at Houston, Houston, Texas, USA.
Claudia PedrozaCenter for Clinical Research and Evidence-Based Medicine, The University of Texas Health Science Center at Houston, Houston, Texas, USA.
Charles GreenCenter for Clinical Research and Evidence-Based Medicine, The University of Texas Health Science Center at Houston, Houston, Texas, USA.
Jon E TysonCenter for Clinical Research and Evidence-Based Medicine, The University of Texas Health Science Center at Houston, Houston, Texas, USA.
Ethan A TaubDepartment of Surgery, The University of Texas Health Science Center at Houston, Houston, Texas, USA.
David E MeyerDepartment of Surgery, The University of Texas Health Science Center at Houston, Houston, Texas, USA.
Laura J MooreDepartment of Surgery, The University of Texas Health Science Center at Houston, Houston, Texas, USA.
Rondel AlbaradoDepartment of Surgery, The University of Texas Health Science Center at Houston, Houston, Texas, USA.
Michelle K McNuttDepartment of Surgery, The University of Texas Health Science Center at Houston, Houston, Texas, USA.
Lillian S KaoDepartment of Surgery, The University of Texas Health Science Center at Houston, Houston, Texas, USA.
Charles E WadeDepartment of Surgery, The University of Texas Health Science Center at Houston, Houston, Texas, USA.
John B HolcombCenter for Injury Science, The University of Alabama at Birmingham School of Medicine, Birmingham, Alabama, USA.
The University of Texas Health Science Center at Houston · USCenter for Clinical Research (United States) · USUniversity of Alabama at Birmingham · US

Funding

Convalescent Plasma to Limit Coronavirus Associated ComplicationsUL1TR003167 · NCATS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI KARP, DANIEL D, MCPHERSON, DAVID D · 2019 to 2023
$45.3M
Institutional Career Development CoreKL2TR003168 · NCATS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MILLER, CHARLES C · 2019 to 2023
$4.9M
NCATS NIH HHS KL2 TR003168NCATS NIH HHS UL1 TR003167
6 · The paper itself

Abstract

backgroundAlthough widely used in treating severe abdominal trauma, damage control laparotomy (DCL) has not been assessed in any randomized controlled trial. We conducted a pilot trial among patients for whom our surgeons had equipoise and hypothesized that definitive laparotomy (DEF) would reduce major abdominal complications (MAC) or death within 30 days compared with DCL.

methodsEligible patients undergoing emergency laparotomy were randomized during surgery to DCL or DEF from July 2016 to May 2019. The primary outcome was MAC or death within 30 days. Prespecified frequentist and Bayesian analyses were performed.

resultsOf 489 eligible patients, 39 patients were randomized (DCL 18, DEF 21) and included. Groups were similar in demographics and mechanism of injury. The DEF group had a higher Injury Severity Score (DEF median 34 (IQR 20, 43) vs DCL 29 (IQR 22, 41)) and received more prerandomization blood products (DEF median red blood cells 8 units (IQR 6, 11) vs DCL 6 units (IQR 2, 11)). In unadjusted analyses, the DEF group had more MAC or death within 30 days (1.71, 95% CI 0.81 to 3.63, p=0.159) due to more deaths within 30 days (DEF 33% vs DCL 0%, p=0.010). Adjustment for Injury Severity Score and prerandomization blood products reduced the risk ratio for MAC or death within 30 days to 1.54 (95% CI 0.71 to 3.32, p=0.274). The Bayesian probability that DEF increased MAC or death within 30 days was 85% in unadjusted analyses and 66% in adjusted analyses.

conclusionThe findings of our single center pilot trial were inconclusive. Outcomes were not worse with DCL and, in fact, may have been better. A randomized clinical trial of DCL is feasible and a larger, multicenter trial is needed to compare DCL and DEF for patients with severe abdominal trauma. LEVEL OF EVIDENCE: Level II.

Indexed as

abdominal injuriesemergency treatmentlaparotomypostoperative complications

Identifiers

PMID34423135
PMCPMC8323393
OpenAlexW3187349707

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.